ArticleNPJ Parkinson's disease2018

Proteasome-targeted nanobodies alleviate pathology and functional decline in an α-synuclein-based Parkinson's disease model.

Diptaman Chatterjee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.